Safety and efficacy of magnetic anchoring electrode-assisted irreversible electroporation for gastric tissue ablation



Irreversible electroporation (IRE) is an emerging tissue ablation technique, which is safe for sites where thermal-basis techniques are not suitable. The aim of this study is to evaluate the safety and efficacy of magnetic anchoring electrode (MAE)-assisted IRE for normal gastric tissue ablation in a rabbit model.


IRE (500 V, 100 μs, 99 pulses, 1 Hz) of the gastric wall was performed in 24 adult New Zealand rabbits with a novel catheter-mounted MAE with fluoroscopy and a surgical approach. Procedure time, procedure-related bleeding, perforation, and other complications were recorded. Animals were sacrificed at 30 min, 1 day, 3 days, 7 days, 14 days, and 28 days post-IRE. The stomach was removed en bloc, and the diameter of each lesion was measured. Histopathological analyses by Hematoxylin–Eosin (H&E), masson trichrome, alpha-smooth muscle action (α-SMA), and terminal-deoxynucleotidyl transferase mediated nick end labeling (TUNEL) were performed.


Gastric tissue ablation with MAE-assisted IRE was successfully performed without any interruption. No perforation or bleeding was observed during IRE or throughout the follow-up period. A demarcated hemorrhage was found in the ablated area upon gross examination. H&E staining showed complete cell death with inflammatory infiltration, edema, and hemorrhaging. TUNEL presented diffuse positive cells in the ablated area. The tissue scaffold was well preserved without damage as indicated by Masson trichrome staining. Ulceration was observed starting from 3 days post-IRE. The mucosal layer was gradually recovered and regenerated within 14–28 days. No other complication was observed post-IRE.


MAE-assisted IRE is safe and effective for normal gastric tissue ablation and the gastric wall recovered in 14–28 days post-IRE.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6


  1. 1.

    Charalampakis N, Economopoulou P, Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA, Psyrri A (2018) Medical management of gastric cancer: a 2017 update. Cancer Med 7:123–133.

  2. 2.

    Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, Park SR, Fujii M, Kang YK, Chen LT (2013) Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 14:e535–e547.

  3. 3.

    Lim KT (2017) Surgical treatment of gastrointestinal stromal tumors of the stomach: current status and future perspective. Transl Gastroenterol Hepatol 2:104.

  4. 4.

    Virgilio E, Balducci G, Mercantini P, Giarnieri E, Giovagnoli MR, Montagnini M (2018) Laparoscopic intragastric surgery for treating early gastric cancer. Anticancer Res 38:1911–1916.

  5. 5.

    Berlth F, Yang HK (2018) Minimal-invasive gastrectomy: what the west can learn from the east? Updates Surg 70:181–187.

  6. 6.

    Maple JT, Abu Dayyeh BK, Chauhan SS, Hwang JH, Komanduri S, Manfredi M, Konda V, Murad FM, Siddiqui UD, Banerjee S (2015) Endoscopic submucosal dissection. Gastrointest Endosc 81:1311–1325.

  7. 7.

    Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802.

  8. 8.

    Strauss AC, Agoston AT, Dulai PS, Srivastava A, Rothstein RI (2014) Radiofrequency ablation for Barrett’s-associated intramucosal carcinoma: a multi-center follow-up study. Surg Endosc 28:3366–3372.

  9. 9.

    Steel AW, Postgate AJ, Khorsandi S, Nicholls J, Jiao L, Vlavianos P, Habib N, Westaby D (2011) Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc 73:149–153.

  10. 10.

    Srimathveeravalli G, Cornelis F, Wimmer T, Monette S, Kimm SY, Maybody M, Solomon SB, Coleman JA, Durack JC (2017) Normal porcine ureter retains lumen wall integrity but not patency following catheter-directed irreversible electroporation: imaging and histologic assessment over 28 days. J Vasc Interv Radiol 28:913–919.e1.

  11. 11.

    Davalos RV, Mir LM, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231.

  12. 12.

    Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 6:37–48.

  13. 13.

    Phillips M, Maor E, Rubinsky B (2011) Principles of tissue engineering with nonthermal irreversible electroporation. J Heat Transfer 133:011004.

  14. 14.

    Faroja M, Ahmed M, Appelbaum L, Ben-David E, Moussa M, Sosna J, Nissenbaum I, Goldberg SN (2013) Irreversible electroporation ablation: is all the damage nonthermal? Radiology 266:462–470.

  15. 15.

    Ueshima E, Schattner M, Mendelsohn R, Gerdes H, Monette S, Takaki H, Durack JC, Solomon SB, Srimathveeravalli G (2018) Transmural ablation of the normal porcine common bile duct with catheter-directed irreversible electroporation is feasible and does not affect duct patency. Gastrointest Endosc 87:300.e1–300.e6.

  16. 16.

    Neven K, Van Es R, Van Driel V, Van Wessel H, Fidder H, Vink A, Doevendans P, Wittkampf F (2017) Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus. Circ Arrhythmia Electrophysiol 10:1–8.

  17. 17.

    Maor E, Ivorra A, Mitchell JJ, Rubinsky B (2010) Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 21:1708–1715.

  18. 18.

    Phillips MA, Narayan R, Padath T, Rubinsky B (2012) Irreversible electroporation on the small intestine. Br J Cancer 106:490–495.

  19. 19.

    Srimathveeravalli G, Silk M, Wimmer T, Monette S, Kimm S, Maybody M, Solomon SB, Coleman J, Durack JC (2015) Feasibility of catheter-directed intraluminal irreversible electroporation of porcine ureter and acute outcomes in response to increasing energy delivery. J Vasc Interv Radiol 26:1059–1066.

  20. 20.

    Srimathveeravalli G, Wimmer T, Monette S, Gutta NB, Ezell PC, Maybody M, Weiser MR, Solomon SB (2013) Evaluation of an endorectal electrode for performing focused irreversible electroporation ablations in the swine rectum. J Vasc Interv Radiol 24:1249–1256.

  21. 21.

    Stillström D, Nilsson H, Jesse M, Peterhans M, Jonas E, Freedman J (2017) A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas. Surg Endosc 31:1982–1985.

  22. 22.

    Wang HY, Bhunia AK, Lu C (2006) A microfluidic flow-through device for high throughput electrical lysis of bacterial cells based on continuous dc voltage. Biosens Bioelectron 22:582–588.

  23. 23.

    Lee JM, Choi HS, Chun HJ, Kim ES, Keum B, Seo YS, Jeen YT, Lee HS, Um SH, Kim CD, Kim HB (2019) EUS-guided irreversible electroporation using endoscopic needle-electrode in porcine pancreas. Surg Endosc 33:658–662.

  24. 24.

    Sánchez-Velázquez P, Castellví Q, Villanueva A, Quesada R, Pañella C, Cáceres M, Dorcaratto D, Andaluz A, Moll X, Trujillo M, Burdió JM, Berjano E, Grande L, Ivorra A, Burdió F (2016) Irreversible electroporation of the liver: is there a safe limit to the ablation volume? Sci Rep 6:23781.

  25. 25.

    Martin RCG, Durham AN, Besselink MG, Iannitti D, Weiss MJ, Wolfgang CL, Huang KW (2016) Irreversible electroporation in locally advanced pancreatic cancer: a call for standardization of energy delivery. J Surg Oncol 114:865–871.

  26. 26.

    Dobashi A, Storm AC, Wong Kee Song LM, Gostout CJ, Deters JL, Miller CA, Knipschield MA, Rajan E (2019) Efficacy and safety of an internal magnet traction device for endoscopic submucosal dissection: ex vivo study in a porcine model (with video). Surg Endosc 33:663–668.

  27. 27.

    Dobashi A, Wu SW, Deters JL, Miller CA, Knipschield MA, Cameron GP, Lu L, Rajan E, Gostout CJ (2019) Endoscopic magnet placement into subadventitial tunnels for augmenting the lower esophageal sphincter using submucosal endoscopy: ex vivo and in vivo study in a porcine model (with video). Gastrointest Endosc 89:422–428.

  28. 28.

    Shang Y, Guo H, Zhang D, Xue F, Yan X, Shi A, Dong D, Wang S, Ma F, Wang H, Li J, Liu X, Luo R, Wu R, Lv Y (2017) An application research on a novel internal grasper platform and magnetic anchoring guide system (MAGS) in laparoscopic surgery. Surg Endosc 31:274–280.

  29. 29.

    Matsuzaki I, Hattori M, Hirose K, Esaki M, Yoshikawa M, Yokoi T, Kobayashi M, Miyahara R, Hirooka Y, Goto H (2018) Magnetic anchor–guided endoscopic submucosal dissection for gastric lesions (with video). Gastrointest Endosc 87:1576–1580.

  30. 30.

    On R, Technology E (2013) Magnets in the GI tract. Gastrointest Endosc 78:561–567.

  31. 31.

    Rivas H, Robles I, Riquelme F, Vivanco M, Jiménez J, Marinkovic B, Uribe M (2018) Magnetic surgery: results from first prospective clinical trial in 50 patients. Ann Surg 267:88–93.

  32. 32.

    Kumar N, Aihara H, Thompson C, Ryou M, Ryan M (2014) A novel magnetic countertraction device for endoscopic submucosal dissection significantly reduces procedure time and minimizes technical difficulty. Endoscopy 46:422–425.

  33. 33.

    Kodama H, Vroomen LG, Ueshima E, Reilly J, Brandt W, Paluch LR, Monette S, Jones D, Solomon SB, Srimathveeravalli G (2018) Catheter-based endobronchial electroporation is feasible for the focal treatment of peribronchial tumors. J Thorac Cardiovasc Surg 155:2150–2159.e3.

  34. 34.

    Li J, Zeng J, Chen J, Shi J, Luo X, Fang G, Chai W, Zhang W, Liu T, Niu L (2017) Evaluation of the safety of irreversible electroporation on the stomach wall using a pig model. Exp Ther Med 14:696–702.

Download references


This work was supported by a grant of National Key R&D Project of China (No. 2018YFC0115300), National Natural Science Foundation of China (No. 81727802), and the Fundamental Research Funds for the Central Universities (No. SXJH012019076). In addition, we would like to thank Dr. Aihua Shi from National Local Joint Engineering Research Center for Precision Surgery and Regenerative Medicine, First Affiliated Hospital of Xi’an Jiaotong University for the fabrication of magnetic anchoring electrode.

Author information

FGR, LSH, XPY, DKC, RQW, and YL designed the study; FGR, QSL, ZYG, JZ, WMG, ZZ, and PKC performed the animal study; FGR, QSL, XC, and DKC performed the data analysis and interpretation; FGR, QSL, LSH, and XPY drafted the manuscript; RQW and YL revised the manuscript; all authors approved the final manuscript.

Correspondence to Yi Lv.

Ethics declarations


Fenggang Ren, Qingshan Li, Liangshuo Hu, Xiaopeng Yan, Zhongyang Gao, Jing Zhang, Weiman Gao, Zhe Zhang, Pengkang Chang, Xue Chen, Dake Chu, Rongqian Wu, and Yi Lv have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ren, F., Li, Q., Hu, L. et al. Safety and efficacy of magnetic anchoring electrode-assisted irreversible electroporation for gastric tissue ablation. Surg Endosc 34, 580–589 (2020).

Download citation


  • Irreversible electroporation
  • Gastric tissue ablation
  • Magnetic anchoring
  • Pulsed electric fields